2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

Adjei, A.; Adjei, Alex; Baas, P.; Baas, Paul; Besse, B.; Besse, Benjamin; Bubendorf, Lukas; Crinò, Lucio; De Leyn, Paul; De Ruysscher, Dirk; Dooms, Christophe; Douillard, Jean-Yves; Eberhardt, Wilfried; Edelman, Martin; Faivre-Finn, Corinne; Felip, E.; Felip, Enriqueta; Kerr, Keith; Le Pechoux, Cecile; Lim, Eric; Marchetti, Antonio; Meldgaard, P.; Meldgaard, Peter; Mok, Tony; Nicolson, M.; Nicolson, Marianne; Novello, Silvia; O'Byrne, Ken; Paz-Ares, L.; Paz-Ares, Luis; Peters, S.; Peters, Solange; Reck, M.; Reck, Martin; Rocco, Gaetano; Senan, Suresh; Smit, E. F.; Smit, Egbert F.; Stahel, R.; Stahel, Rolf; Syrigos, K.; Syrigos, Konstantinos; Van Schil, Paul; Vansteenkiste, Johan; Veronesi, Giulia; Weder, Walter; Westeel, Virginie

research

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

Abstract

This manuscript provides recommendations for first-line / second and further lines of treatment in advanced disease in non-small cell lung cancer (NSCLC). These recommendations were developed during the 2nd ESMO Consensus Conference on Lung Cancer in May 201

Similar works

Full text

Open in the Core reader

Download PDF

Available Versions

RERO DOC Digital Library

oai:doc.rero.ch:293467

Last time updated on 25/08/2017